Figure 4 | Scientific Reports

Figure 4

From: Identification of m6A/m5C-related lncRNA signature for prediction of prognosis and immunotherapy efficacy in esophageal squamous cell carcinoma

Figure 4

Construction of lncRNAs signature-based RiskScroe system for prognosis prediction. (A,B) Construction of the RiskScore model using the lasso method. (C) Lasso coefficients of the 10 prognostic genes. (D) Survival analysis of ESCC patients in high- and low- RiskScore cohorts. (E) ROC curve of the RiskScore at 1-, 2- and 3-year follow-up. (F–H) Distribution of RiskScore, status, and expression of m6A/m5C-lncRNAs in the TCGA.

Back to article page